DIPHENYLHYDANTOIN HALF‐LIFE IN MAN AND ITS INHIBITION BY PHENYLBUTAZONE: THE ROLE OF GENETIC FACTORS
- 12 January 1973
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 193 (1-6), 561-564
- https://doi.org/10.1111/j.0954-6820.1973.tb10628.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- EFFECTS OF ENVIRONMENTAL CHEMICALS ON THE METABOLISM OF DRUGS, CARCINOGENS, AND NORMAL BODY CONSTITUENTS IN MANAnnals of the New York Academy of Sciences, 1971
- Individual Differences in the Plasma Half‐lives of Lipid Soluble Drugs in ManActa Pharmacologica et Toxicologica, 1971
- Genetic and environmental influence on halothane metabolism in twinsClinical Pharmacology & Therapeutics, 1971
- Impairment of Drug Metabolism in Man by Allopurinol and NortriptylineNew England Journal of Medicine, 1970
- Effects of phenylbutazone on liver microsomal demethylaseBiochemical Pharmacology, 1970
- Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in manJCI Insight, 1969
- THE INFLUENCE OF PHENOBARBITAL ON THE HALF‐LIFE OF DIPHENYLHYDANTOIN IN MANActa Medica Scandinavica, 1969
- Genetic control of dicumarol levels in manJCI Insight, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968
- DICOUMAROL-INDUCED DIPHENYLHYDANTOIN INTOXICATIONThe Lancet, 1966